Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Gram-Negative and Gram-Positive Bacterial Research

Executive Summary: Meropenem trihydrate is a broad-spectrum β-lactam antibiotic that inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins (PBPs), resulting in bacterial cell lysis and death (Dixon et al., 2025). It shows low minimum inhibitory concentration (MIC₉₀) values against key clinical pathogens, including Escherichia coli and Klebsiella pneumoniae, at physiological pH 7.5 (APExBIO). Resistance to carbapenems in Enterobacterales is largely mediated by carbapenemase production, efflux pumps, and porin mutations (Dixon et al., 2025). Metabolomics provides new diagnostic insights into resistance phenotypes, enabling rapid CPE identification (Dixon et al., 2025). APExBIO's Meropenem trihydrate (SKU B1217) is validated for research use, supporting robust, reproducible workflows in antibacterial research (Aminoallyl-UTP-X-Cy5.com).

Biological Rationale

Carbapenem antibiotics, including Meropenem trihydrate, are critical in both clinical and research settings due to their broad-spectrum activity against multidrug-resistant bacteria (Dixon et al., 2025). They are effective against a wide array of gram-negative and gram-positive pathogens, including Enterobacterales, Pseudomonas aeruginosa, and Streptococcus pneumoniae. Their low susceptibility to β-lactamase-mediated hydrolysis makes them essential for studying resistance mechanisms and testing new antibacterial strategies. The rising prevalence of carbapenemase-producing Enterobacterales (CPE) highlights the need for reliable compounds for resistance modeling and phenotyping (B-Interleukin-II-44-56.com). This article extends previous discussions by integrating the latest metabolomics-driven insights into resistance phenotyping, clarifying the molecular rationale behind Meropenem trihydrate's research utility.

Mechanism of Action of Meropenem Trihydrate

Meropenem trihydrate is a β-lactam antibiotic belonging to the carbapenem class. It acts by binding to penicillin-binding proteins (PBPs) in bacterial cell membranes, primarily PBP2 and PBP3. This binding inhibits the final transpeptidation step in peptidoglycan synthesis, compromising cell wall integrity and leading to osmotic cell lysis (APExBIO). Meropenem trihydrate demonstrates broad activity by effectively inhibiting PBPs in both gram-negative and gram-positive organisms, including E. coli, K. pneumoniae, Enterobacter spp., and Streptococcus spp. It is stable against most β-lactamases, including extended-spectrum β-lactamases (ESBLs), but hydrolysis can occur via carbapenemases such as KPC, NDM, and OXA-48 (Dixon et al., 2025). The MIC₉₀ for Meropenem trihydrate is typically ≤0.12–1 µg/mL for susceptible strains at pH 7.5.

Evidence & Benchmarks

• Carbapenem antibiotics such as Meropenem trihydrate are effective against both gram-negative and gram-positive bacteria, with MIC₉₀ values for E. coli and K. pneumoniae typically ≤0.12–0.25 µg/mL at pH 7.5 (APExBIO).
• Metabolomics can discriminate carbapenemase-producing Enterobacterales (CPE) from non-CPE isolates within 7 hours based on 21 metabolite biomarkers, with AUROC ≥ 0.845 (Dixon et al., 2025).
• Meropenem trihydrate displays improved antibacterial activity at physiological pH 7.5 versus acidic pH 5.5, as measured by MIC values (APExBIO).
• In acute necrotizing pancreatitis rat models, Meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection compared to controls (APExBIO).
• It is soluble in water (≥20.7 mg/mL with gentle warming) and DMSO (≥49.2 mg/mL), but insoluble in ethanol; optimal storage is at -20°C (APExBIO).
• Three principal carbapenem resistance mechanisms in Enterobacterales: carbapenemase enzyme production, efflux pump overexpression, and porin loss/mutation (Dixon et al., 2025).
• Advanced metabolomics approaches (LC-MS/MS) provide mechanistic and diagnostic insights into resistance pathways, including arginine metabolism and biofilm formation (Dixon et al., 2025).

This article clarifies and updates prior protocol-based resources (e.g., Aminoallyl-UTP-X-Cy5.com) by integrating the latest metabolomic benchmarks and standardized evidence claims.

Applications, Limits & Misconceptions

Meropenem trihydrate is widely used in research for:

• Antibiotic susceptibility and resistance mechanism studies in gram-negative and gram-positive bacteria.
• Phenotypic screening for carbapenemase production using both culture and metabolomic assays.
• Modeling bacterial infection and treatment response in animal models.
• Validating new diagnostic platforms for CPE detection.
• Evaluating combinatorial effects with adjuvants, such as iron chelators (e.g., deferoxamine).

Researchers should be aware of several limitations and misconceptions around Meropenem trihydrate:

Common Pitfalls or Misconceptions

• Not a clinical or diagnostic product: Meropenem trihydrate from APExBIO is intended strictly for research use, not for therapeutic or diagnostic applications (APExBIO).
• Hydrolysis by certain carbapenemases: While stable to most β-lactamases, it is susceptible to hydrolysis by carbapenemases (e.g., KPC, NDM, OXA-48), necessitating confirmation of resistance phenotype during assays (Dixon et al., 2025).
• Decreased activity at acidic pH: MIC values increase at pH 5.5, potentially confounding results in non-physiological assay conditions (APExBIO).
• Solubility constraints: Insoluble in ethanol; for high-concentration stocks, use DMSO or water with gentle warming (APExBIO).
• Short-term solution stability: Solutions are recommended for short-term use only; long-term storage of reconstituted stocks may result in degradation (APExBIO).

This article extends prior scenario-based guides (3-dgtp.com) by providing mechanistic clarifications and highlighting metabolomic diagnostic advances.

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217) is supplied as a solid, with validated solubility in water (≥20.7 mg/mL with gentle warming) and DMSO (≥49.2 mg/mL). Prepare solutions fresh or store aliquots at -20°C for optimal stability (APExBIO). For susceptibility testing, prepare serial dilutions at pH 7.5 in appropriate media. Use as a reference compound in MIC, MBC, and time-kill assays. In resistance modeling, combine with metabolomic profiling (e.g., LC-MS/MS) to correlate phenotypic and metabolic markers (Dixon et al., 2025). For animal studies, administer per established protocols and ensure compliance with ethical guidelines. For further workflow optimization, see related guides on mechanistic insights and resistance phenotyping (B-Interleukin-II-44-56.com), which this article updates by incorporating new data on diagnostic metabolite signatures.

Conclusion & Outlook

Meropenem trihydrate remains an indispensable research antibiotic for investigating both susceptibility and resistance in gram-negative and gram-positive bacteria. Its robust β-lactamase stability and validated MIC profiles underpin its status as a gold standard for antibacterial research. The integration of metabolomics now allows rapid, data-driven resistance phenotyping, supporting translational advances in infection control and diagnostics (Dixon et al., 2025). APExBIO’s Meropenem trihydrate (SKU B1217) provides researchers with a reliable, reproducible tool for next-generation antibacterial and resistance studies. For protocols, technical specifications, and ordering, consult the official product page.